Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock

左旋西孟旦 变向性 心源性休克 医学 多巴酚丁胺 心肌梗塞 心脏病学 科克伦图书馆 内科学 心脏外科 重症监护医学 休克(循环) 麻醉 血流动力学 荟萃分析
作者
Amanda Shabana,Farzan Dholoo,Prithwish Banerjee
出处
期刊:Current Heart Failure Reports [Springer Science+Business Media]
被引量:1
标识
DOI:10.1007/s11897-020-00493-9
摘要

Worldwide, cardiogenic shock (CS) is the leading cause of death in patients admitted with an acute myocardial infarction (AMI). CS is characterised by reduced cardiac output secondary to systolic dysfunction which can lead to multi-organ failure. The mainstay of medical treatment in CS are inotropes and vasopressors to improve cardiac output. However, current clinical guidelines do not direct clinicians as to which agents to use and in what combinations. This article aims to review the current evidence on the management of CS with a major focus on the use of inotropes and vasopressors. A literature review was conducted analysing published literature from the following databases: PubMed, MedLine, Cochrane Library and Embase, as well as a manual search of articles that were deemed relevant. Relevant articles were identified by using keywords such as “cardiogenic shock”. Literature was assessed to review the use of inotropes and vasopressors in CS. Dopamine and adrenaline were associated with increased mortality and arrhythmias. Dobutamine was associated with an improvement in cardiac output, at the determinant of causing arrhythmias. Conversely, noradrenaline was associated with a lower likelihood of arrhythmias and most importantly decreased mortality in CS. Compared to other inotropes, levosimendan appears to have a better safety profile and is associated with decreased mortality in CS, particularly when combined with a vasopressor. Our literature review suggests that treatment combination of the inotrope levosimendan with the vasopressor noradrenaline may be the most effective management option in CS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Feny发布了新的文献求助10
刚刚
GingerF的应助被Tuniverse_采纳,获得100
刚刚
科研通AI6.4的应助被miao采纳,获得10
刚刚
刚刚
千贝儿完成签到,获得积分10
刚刚
wy发布了新的文献求助10
1秒前
sunstar完成签到,获得积分10
1秒前
悦耳安萱完成签到 ,获得积分10
1秒前
Ava的应助被111采纳,获得10
2秒前
hui完成签到,获得积分10
2秒前
111发布了新的文献求助10
2秒前
3秒前
3秒前
科研通AI6.3的应助被酱鱼采纳,获得10
4秒前
lunna发布了新的文献求助10
4秒前
ss完成签到,获得积分10
4秒前
学习牛马发布了新的文献求助30
4秒前
5秒前
甘甘甘甘的应助被科研通管家采纳,获得30
5秒前
Jasper的应助被cai采纳,获得10
5秒前
科研通AI2S的应助被科研通管家采纳,获得10
5秒前
无极微光的应助被科研通管家采纳,获得20
5秒前
打打的应助被科研通管家采纳,获得10
6秒前
情怀的应助被科研通管家采纳,获得10
6秒前
04d的应助被科研通管家采纳,获得10
6秒前
田様的应助被科研通管家采纳,获得10
6秒前
6秒前
6秒前
小蘑菇的应助被wei采纳,获得10
6秒前
852的应助被科研通管家采纳,获得10
6秒前
斯文败类的应助被bam采纳,获得10
6秒前
orixero的应助被科研通管家采纳,获得10
6秒前
香蕉觅云的应助被科研通管家采纳,获得10
7秒前
斯文败类的应助被科研通管家采纳,获得10
7秒前
英俊的铭的应助被科研通管家采纳,获得10
7秒前
酷波er的应助被科研通管家采纳,获得10
7秒前
深情安青的应助被科研通管家采纳,获得10
7秒前
所所的应助被科研通管家采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192209
求助须知:如何正确求助?哪些是违规求助? 9578801
关于积分的说明 21861940
捐赠科研通 7791695
什么是DOI,文献DOI怎么找? 3436846
关于科研通互助平台的介绍 2560562
邀请新用户注册赠送积分活动 2483617